A1LN34:BVMF
Alnylam Pharmaceuticals Inc Bdr
R$55.00
arrow_upward
+5.87%(+3.05) 1D
Aug 3, 2:23:33 PM GMT-3 · BRL
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1LN34...
Open
R$53.00
High
R$56.00
Low
R$52.51
Mkt. cap
28.98B
Avg. vol.
953.00
Volume
2.07K
52-wk high
R$132.40
52-wk low
R$50.25
Shares outstanding
133.81M
No. of employees
2K
Open
R$53.00
High
R$56.00
Low
R$52.51
Mkt. cap
28.98B
Avg. vol.
953.00
Volume
2.07K
52-wk high
R$132.40
52-wk low
R$50.25
Shares outstanding
133.81M
No. of employees
2K
News stories
From sources across the web
Investing.com Canada
·
4 hours ago
Why is Alnylam Pharmaceuticals stock climbing today? By Investing.com
Investing.com Canada
·
5 hours ago
Alnylam stock rating upgraded to Strong Buy at Raymond James on pipeline potential
Pulse 2.0
·
20 hours ago
Alnylam: AMVUTTRA Revenue Tops $1 Billion, But Pent-Up Demand Normalization Triggers Guidance Cut
Trefis
·
2 days ago
Is The Recent Pullback In Alnylam Stock An Opportunity Or A Trap?
Profile
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list. Wikipedia
About Alnylam Pharmaceuticals Inc Bdr
AI content may include mistakes. Learn more